Larimar Therapeutics
IPOPublic · Bala Cynwyd, United States · $80.0M raised
- Headquarters
- Bala Cynwyd, Pennsylvania
- Employees
- 51–200
- Business Model
- B2B
- Website
- larimartx.com
- Total Funding
- $80.0M
- Last Round
- $80.0M Venture RoundMay 2020
- Rounds
- 1
- Type
- Public
About
Clinical-stage biotech developing treatments for complex rare diseases, with lead compound targeting Friedreich's ataxia.
Summary
Larimar Therapeutics is a Biotech company based in Bala Cynwyd, United States. It has raised $80.0M in total across 1 round, most recently a $80.0M Venture Round round in May 2020. Investors include Deerfield Management.
Tech & App Stack
5 technologies & apps tracked
Create a free account — 10 credits a month to unlock the full tech & app stack, funding history, and valuations.
Sign up to view the funding chart
Create a free account — you'll get 10 credits a month to unlock funding history, valuations, and tech stacks.
Funding History
Feb 2026
Sign up to see all 3 rounds
Full funding history, per-round amounts, and investor participation.
Investors
Similar Companies
BridgeBio makes targeted treatments for genetic diseases.
Global contract research organization providing comprehensive drug development and laboratory ser...
Global fertility clinics platform
Biotech advancing cellular rejuvenation programming to restore cell health and reverse disease.
Specialty pharmaceutical company
Biopharmaceutical services company